Parallel mechanistic studies reveal that HKC attenuates inflammatory cell activation and infiltration via p38 mitogen-activated protein kinase (MAPK) pathway inhibition, thereby reducing transforming growth factor beta 1 (TGF-β1) expression in nephropathy models (Chen P. et al., 2012). Here, TGFB1 is linked to kidney disorder.